Actualités Avacta - AVCT | Actions London Stock Exchange

Avacta Group PLC Completion of Dose Escalation and RDE Arms

Avacta Group PLC 12 December 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Dose Escalation and Recommended Dose...

Avacta Group PLC R&D Spotlight focusing on pipeline advances

Avacta Group PLC 30 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") R&D Spotlight focusing on pre|CISION®...

Avacta Group PLC Block Listing Six Monthly Return

Avacta Group PLC 28 October 2024 28 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Block Listing...

Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona

Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Reports Pipeline Advances with Two Novel...

Avacta Group PLC Avacta Reports Pipeline Avances at EORTC

Avacta Group PLC 24 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Reports Pipeline Advances with Two...

Avacta Group PLC Issue of Equity and Total Voting Rights

Avacta Group PLC 21 October 2024 Avacta Group plc ("Avacta" or the "Group" or the "Company") Issue of Equity and Total Voting Rights ...

Avacta partners with Tempus to enable AI-driven drug development

Avacta Group PLC on Monday revealed it has agreed to collaborate with AI-focused precision medicine business, Tempus ...

Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology

Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta and Tempus Enter Strategic Collaboration...

Avacta Group PLC Avacta and Tempus Enter Strategic Collaboration

Avacta Group PLC 21 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta and Tempus Enter Strategic...

Avacta expands pipeline with two novel preclinical assets

Avacta Group PLC on Thursday revealed it has expanded its oncology pipeline with two novel preclinical assets. AVA6 ...

Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform

Avacta Group plc ("Avacta" or "the Group" or "the Company")Avacta Expands its Pipeline with Two Novel Assets...

Avacta Group PLC Avacta Expands its Pipeline

Avacta Group PLC 17 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Expands its Pipeline with Two Novel...

Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer

Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Group strengthens executive team with...

EXECUTIVE CHANGES: PHSC co-founder and Deltic Energy CEO depart

The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separa ...

Avacta Group PLC Avacta appoints Chief Scientific Officer

Avacta Group PLC 15 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Group strengthens executive team...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Avacta (AVCT)

Votre Hub pour des idées et discussions en direct en temps réel

AVCT Actualités

Avacta Group PLC Completion of Dose Escalation and RDE Arms

Avacta Group PLC R&D Spotlight focusing on pipeline advances

Avacta Group PLC Block Listing Six Monthly Return

Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona

Avacta Group PLC Avacta Reports Pipeline Avances at EORTC

Avacta Group PLC Issue of Equity and Total Voting Rights

Avacta partners with Tempus to enable AI-driven drug development

Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology

Avacta Group PLC Avacta and Tempus Enter Strategic Collaboration

Avacta expands pipeline with two novel preclinical assets

Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform

Avacta Group PLC Avacta Expands its Pipeline

Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer

EXECUTIVE CHANGES: PHSC co-founder and Deltic Energy CEO depart

Avacta Group PLC Avacta appoints Chief Scientific Officer

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Avacta (AVCT) Actualités

Avacta (AVCT)

Votre Hub pour des idées et discussions en direct en temps réel

AVCT Actualités

Avacta Group PLC Completion of Dose Escalation and RDE Arms

Avacta Group PLC R&D Spotlight focusing on pipeline advances

Avacta Group PLC Block Listing Six Monthly Return

Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona

Avacta Group PLC Avacta Reports Pipeline Avances at EORTC

Avacta Group PLC Issue of Equity and Total Voting Rights

Avacta partners with Tempus to enable AI-driven drug development

Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology

Avacta Group PLC Avacta and Tempus Enter Strategic Collaboration

Avacta expands pipeline with two novel preclinical assets

Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform

Avacta Group PLC Avacta Expands its Pipeline

Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer

EXECUTIVE CHANGES: PHSC co-founder and Deltic Energy CEO depart

Avacta Group PLC Avacta appoints Chief Scientific Officer

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application